WBP2 and uterine cancer: WBP2 is observed to be frequently amplified in 25 out of 32 cancer types, and of which, patients with breast invasive carcinoma (BRCA) have the highest frequency of WBP2 amplification, closely followed by liver and uterine cancers (Fig. 1A).